Translations:Paricalcitol/1/ja

Paricalcitol/1/ja

Clinical data
Trade names	Zemplar
Other names	(1R,3S)-5-[2-[(1R,3aR,7aS)-1-[(2R,5S)-6-hydroxy-5,6-dimethyl-3E-hepten-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-cyclohexane-1,3-diol
AHFS/Drugs.com	Monograph
MedlinePlus	a682335
Pregnancy category	AU: C
Routes of administration	Oral, Intravenous
ATC code	H05BX02 (WHO)
Legal status
Legal status	AU: S4 (Prescription only) CA: ℞-only UK: POM (Prescription only) US: ℞-only
Pharmacokinetic data
Bioavailability	72%
Protein binding	99.8%
Metabolism	Hepatic
Elimination half-life	14-20 hours
Excretion	Faeces (74%), urine (16%)
Identifiers
IUPAC name (1R,3R,7E,17β)-17-[(1R,2E,4S)-5-hydroxy-1,4,5-trimethylhex-2-en-1-yl]-9,10-secoestra-5,7-diene-1,3-diol
CAS Number	131918-61-1 Y
PubChem CID	5281104
IUPHAR/BPS	2791
DrugBank	DB00910 N
ChemSpider	4444552 Y
UNII	6702D36OG5
KEGG	D00930 N
ChEBI	CHEBI:7931 N
ChEMBL	ChEMBL1200622 Y
Chemical and physical data
Formula	C27H44O3
Molar mass	416.646 g·mol−1
InChI InChI=1S/C27H44O3/c1-18(8-9-19(2)26(3,4)30)24-12-13-25-21(7-6-14-27(24,25)5)11-10-20-15-22(28)17-23(29)16-20/h8-11,18-19,22-25,28-30H,6-7,12-17H2,1-5H3/b9-8+,21-11+/t18-,19+,22-,23-,24-,25+,27-/m1/s1 Y Key:BPKAHTKRCLCHEA-UBFJEZKGSA-N Y
NY (what is this?)  (verify)